Pacific Biosciences of California, Inc. Stock Deutsche Boerse AG
Stocks
P09
US69404D1081
Advanced Medical Equipment & Technology
|
Real-time Estimate
Tradegate
08:42:53 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 2.216 EUR | -0.81% |
|
+61.70% | +42.74% |
| Market Cap | 780M 693M 648M 591M 1.11B 75.12B 1.13B 7.84B 3.03B 38.26B 2.93B 2.87B 123B | P/E 2026 * |
-5.7x | P/E 2027 * | -5.41x |
|---|---|---|---|---|---|
| Enterprise Value | 1.25B 1.11B 1.04B 945M 1.78B 120B 1.8B 12.55B 4.86B 61.24B 4.69B 4.59B 197B | EV / Sales 2026 * |
7.86x | EV / Sales 2027 * | 7.08x |
| Free-Float |
91.09% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PACB | Delayed | |
CBOE
| PACB | Real-time | |
|
Tradegate
| P09 | Real-time | |
|
Deutsche Boerse AG
| P09 | Delayed | |
|
Börse Stuttgart
| P09 | Delayed | |
|
Boerse Muenchen
| P09 | Real-time | |
|
Mexican S.E.
| PACB * | End-of-day quote |
Last Transcript: Pacific Biosciences of California, Inc.
| 1 day | -1.07% | ||
| 1 week | +61.70% | ||
| Current month | +4.68% | ||
| 1 month | +96.65% | ||
| 3 months | +46.33% | ||
| 6 months | +92.04% | ||
| Current year | +42.74% |
| 1 week | 1.36 |  | 2.23 |
| 1 month | 1.06 | | 2.23 |
| Current year | 0.93 | | 2.23 |
| 1 year | 0.93 | | 2.3 |
| 3 years | 0.78 | | 9.4 |
| 5 years | 0.78 | | 26.47 |
| 10 years | 0.78 | | 45.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark van Oene
CEO | Chief Executive Officer | 53 | 2026-08-04 |
Jim Gibson
DFI | Director of Finance/CFO | 57 | 2025-03-30 |
Jonas Korlach
CTO | Chief Tech/Sci/R&D Officer | - | 2012-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Bill Ericson
BRD | Director/Board Member | 67 | 2003-12-31 |
Randy Livingston
BRD | Director/Board Member | 72 | 2008-12-31 |
Marshall Mohr
BRD | Director/Board Member | 69 | 2012-01-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.81% | +61.70% | - | - | 780M | |
| -3.34% | -3.81% | +22.95% | +28.91% | 241B | |
| -4.42% | -5.37% | -0.53% | -14.65% | 149B | |
| -1.33% | +0.43% | -8.40% | +37.27% | 142B | |
| -0.96% | -3.25% | -54.90% | -18.12% | 62.65B | |
| -1.31% | -0.63% | +11.64% | +22.96% | 49.1B | |
| -3.27% | -3.56% | +20.28% | +49.06% | 46.99B | |
| +0.73% | +0.21% | -19.27% | -21.22% | 47.13B | |
| -1.23% | +2.58% | -3.86% | +38.57% | 45.65B | |
| -3.15% | -1.11% | +33.06% | +55.18% | 41.81B | |
| Average | -0.84% | +0.29% | +0.11% | +19.78% | 91.69B | |
| Weighted average by Cap. | -0.74% | +0.45% | +3.21% | +18.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 159M 141M 132M 120M 226M 15.3B 230M 1.6B 618M 7.79B 597M 584M 25.03B | 184M 164M 153M 140M 263M 17.75B 266M 1.85B 717M 9.04B 692M 677M 29.03B |
| Net income | -141M -125M -117M -106M -200M -13.54B -203M -1.41B -547M -6.89B -528M -516M -22.14B | -143M -127M -119M -108M -204M -13.78B -207M -1.44B -557M -7.02B -537M -526M -22.54B |
| Net Debt | 469M 416M 389M 355M 668M 45.13B 677M 4.71B 1.82B 22.98B 1.76B 1.72B 73.82B | 525M 466M 436M 397M 747M 50.5B 758M 5.27B 2.04B 25.72B 1.97B 1.93B 82.61B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | €2.170 | -2.86% | 3,950 |
| 26-10-01 | €2.234 | +7.77% | 27,050 |
| 26-09-30 | €2.073 | +46.19% | 11,360 |
| 26-09-29 | €1.418 | -4.83% | 20 |
| 26-09-28 | €1.490 | +11.03% | 3,140 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PACB Stock
- P09 Stock
Select your edition
All financial news and data tailored to specific country editions
